| scholarly article | Q13442814 |
| P50 | author | Torsten Zuberbier | Q124962 |
| Martin Metz | Q37838546 | ||
| Marcus Maurer | Q50039778 | ||
| P2093 | author name string | M Magerl | |
| E Ardelean | |||
| O Güzelbey | |||
| P2860 | cites work | Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy | Q28264284 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | urticaria | Q187440 |
| P304 | page(s) | 1563-1565 | |
| P577 | publication date | 2008-11-01 | |
| P1433 | published in | Allergy | Q2699825 |
| P1476 | title | Successful treatment of solar urticaria with anti-immunoglobulin E therapy | |
| P478 | volume | 63 |
| Q37962812 | A review of UVA-mediated photosensitivity disorders |
| Q38047862 | A review of UVB-mediated photosensitivity disorders |
| Q38091754 | Anti-IgE--emerging opportunities for Omalizumab |
| Q38022183 | Biologic agents in the treatment of urticaria |
| Q26777088 | Chronic spontaneous urticaria: latest developments in aetiology, diagnosis and therapy |
| Q48240292 | Clinical and photobiological response in eight patients with solar urticaria under treatment with omalizumab, and review of the literature. |
| Q91671713 | Clinical impact of omalizumab in refractory chronic urticaria: One centre experience |
| Q52661824 | Consensus Statement for the Diagnosis and Treatment of Urticaria: A 2017 Update. |
| Q38861327 | Controversies and challenges in the management of chronic urticaria |
| Q41187880 | Diagnosis of urticaria |
| Q38394577 | EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders |
| Q37634331 | Effectiveness of omalizumab in a patient with a life-threatening episode of bronchospasm and larynx angioedema after exposure to house dust |
| Q37554168 | IgE-Related Chronic Diseases and Anti-IgE-Based Treatments |
| Q52938044 | Management and treatment of chronic urticaria (CU). |
| Q38217720 | Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria |
| Q38517653 | Off-Label Uses of Omalizumab. |
| Q41482365 | Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells |
| Q41991600 | Omalizumab for chronic urticaria: a case series and overview of the literature |
| Q38310407 | Omalizumab for the treatment of chronic urticaria |
| Q42907091 | Omalizumab for therapy-resistant chronic urticaria with angioedema |
| Q35095218 | Omalizumab, an anti-immunoglobulin E antibody: state of the art. |
| Q38015260 | Physical urticaria |
| Q39387473 | Review of Physical Urticarias and Testing Methods |
| Q92972790 | Solar Urticaria, a Disease with Many Dark Sides: Is Omalizumab the Right Therapeutic Response? Reflections from a Clinical Case Report |
| Q37711874 | Solar urticaria in a 1-year-old infant: diagnosis and management |
| Q53179019 | Successful and long-lasting treatment of solar urticaria with ultraviolet A rush hardening therapy. |
| Q38208428 | The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update |
| Q37605896 | The definition and diagnostic testing of physical and cholinergic urticarias--EAACI/GA2LEN/EDF/UNEV consensus panel recommendations |
| Q52854801 | The definition, diagnostic testing, and management of chronic inducible urticarias - The EAACI/GA(2) LEN/EDF/UNEV consensus recommendations 2016 update and revision. |
| Q42936833 | Therapeutic alternatives for antihistamine-refractory urticaria |
| Q38981770 | Therapy of antihistamine-resistant chronic spontaneous urticaria |
| Q92988172 | Tracing IgE-Producing Cells in Allergic Patients |
| Q34323869 | Treatment of severe cold contact urticaria with omalizumab: case reports |
| Q39414571 | Ultraviolet radiation and skin mast cells: Effects, mechanisms, and relevance for skin diseases |
| Q37856874 | What to do with refractory urticaria patients |
Search more.